{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:41:33Z","timestamp":1792291293110,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006016","name":"College of Medicine, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejmech.2022.114525","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T19:00:16Z","timestamp":1654801216000},"page":"114525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Azole inhibitors of mushroom and human tyrosinases: Current advances and prospects of drug development for melanogenic dermatological disorders"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0776-9528","authenticated-orcid":false,"given":"Usman","family":"Ghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1152\/physrev.1950.30.1.91","article-title":"Biochemistry of melanin formation","volume":"30","author":"Lerner","year":"1950","journal-title":"Physiol. Rev."},{"issue":"Pt 24","key":"10.1016\/j.ejmech.2022.114525_bib2","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1242\/jcs.040667","article-title":"Melanosomes at a glance","volume":"121","author":"Wasmeier","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.1928.8.2.245","article-title":"The aerobic oxidases","volume":"8","author":"Raper","year":"1928","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)35614-X","article-title":"The chemistry of melanin; mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase","volume":"172","author":"Mason","year":"1948","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/chem.201704410","article-title":"Structure and function of human tyrosinase and tyrosinase-related proteins","volume":"24","author":"Lai","year":"2018","journal-title":"Chemistry"},{"issue":"33","key":"10.1016\/j.ejmech.2022.114525_bib6","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1002\/anie.201704616","article-title":"Structure of human tyrosinase related protein 1 reveals a binuclear zinc active site important for melanogenesis","volume":"56","author":"Lai","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114525_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0020-711X(87)90095-4","article-title":"Mammalian tyrosinase--the critical regulatory control point in melanocyte pigmentation","volume":"19","author":"Hearing","year":"1987","journal-title":"Int. J. Biochem."},{"issue":"30","key":"10.1016\/j.ejmech.2022.114525_bib8","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1039\/D0SC02262D","article-title":"Chemoenzymatic elaboration of the Raper-Mason pathway unravels the structural diversity within eumelanin pigments","volume":"11","author":"Ni","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib9","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9232","article-title":"The role of Wnt\/b-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines","volume":"7","author":"Kovacs","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4838(94)00204-T","article-title":"Tyrosinase: a comprehensive review of its mechanism","volume":"1247","author":"S\u00e1nchez-Ferrer","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2022.114525_bib11","doi-asserted-by":"crossref","first-page":"1493e1506","DOI":"10.1007\/s00018-009-8703-8","article-title":"Cellular mechanisms regulating human melanogenesis","volume":"66","author":"Park","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2017.06.018","article-title":"Precise role of dermal fibroblasts on melanocyte pigmentation","volume":"88","author":"Wang","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2011.08.043","article-title":"Inhibition of the p38 and PKA signaling pathways is associated with the anti-melanogenic activity of Qian-wang-hong-Bai-san, a Chinese herbal formula, in B16 cells","volume":"141","author":"Tsang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114525_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2007.10.003","article-title":"Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways","volume":"28","author":"Newton","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2022.114525_bib15","first-page":"95","article-title":"Cochlear melanocytes and MITF signaling","volume":"6","author":"Tachibana","year":"2001","journal-title":"JIDSP"},{"key":"10.1016\/j.ejmech.2022.114525_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2022.114525_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2010.09.007","article-title":"Involvement of p38 MAPK signaling pathway in the anti-melanogenic effect of San-Bai-tang, a Chinese herbal formula, in B16 cells","volume":"132","author":"Ye","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114525_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cellsig.2017.09.004","article-title":"Recent development of signaling pathways inhibitors of melanogenesis","volume":"40","author":"Pillaiyar","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2022.114525_bib19","series-title":"Current and Emerging Treatments for Albinism","author":"Liu","year":"2020"},{"issue":"17","key":"10.1016\/j.ejmech.2022.114525_bib20","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1021\/acs.jmedchem.7b00967","article-title":"Inhibitors of melanogenesis: an updated review","volume":"61","author":"Pillaiyar","year":"2018","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114525_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson's disease","volume":"129","author":"Segura-Aguilar","year":"2014","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114525_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063136","article-title":"Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease","volume":"8","author":"Schmidt","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JPD-171263","article-title":"Parkinson's disease and melanoma: Co-occurrence and mechanisms","volume":"8","author":"Bose","year":"2018","journal-title":"J. Parkinsons Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114525_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/jdv.14952","article-title":"Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non-melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population","volume":"32","author":"Ibler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114525_bib27","first-page":"532","article-title":"AVS-1357 inhibits melanogenesis via prolonged ERK activation","volume":"64","author":"Kim","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2022.114525_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/1523-1747.ep12476630","article-title":"Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes","volume":"100","author":"Iozumi","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2022.114525_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1248\/bpb.26.1039","article-title":"Melanin biosynthesis inhibitors from the bark of Machilus thunbergii","volume":"26","author":"Li","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2022.114525_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2133.2006.07210.x","article-title":"Alterations in the epidermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin","volume":"155","author":"Unver","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2022.114525_bib31","series-title":"The Pigmentary System: Physiology and Pathophysiology","first-page":"909","article-title":"Mixed epidermal and dermal hypermelanoses","author":"Urabe","year":"1998"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114525_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.2042-7158.1994.tb03253.x","article-title":"Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase","volume":"46","author":"Cabanes","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114525_bib33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.biopha.2018.12.006","article-title":"Kojic acid applications in cosmetic and pharmaceutical preparations","volume":"110","author":"Saeedi","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib34","first-page":"28","article-title":"Are natural ingredients effective in the management of hyperpigmentation? A systematic review","volume":"11","author":"Hollinger","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ejmech.2022.114525_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sder.2009.04.001","article-title":"Management of hyperpigmentation in darker racial ethnic groups","volume":"28","author":"Grimes","year":"2009","journal-title":"Semin. Cutan. Med. Surg."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0738-081X(89)90061-8","article-title":"Azelaic acid therapy in disorders of pigmentation","volume":"7","author":"Breathnach","year":"1989","journal-title":"Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114525_bib37","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/pro.2734","article-title":"Structure-function correlations in tyrosinases","volume":"24","author":"Kanteev","year":"2015","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.syapm.2005.07.012","article-title":"Bacterial tyrosinases","volume":"29","author":"Claus","year":"2006","journal-title":"Syst. Appl. Microbiol."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114525_bib39","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3390\/molecules25122754","article-title":"Recent trends in controlling the enzymatic browning of fruit and vegetable products","volume":"25","author":"Moon","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114525_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.foodchem.2017.09.054","article-title":"Novel hydroxypyridinone derivatives containing an oxime ether moiety: synthesis, inhibition on mushroom tyrosinase and application in antibrowning of fresh-cut apples","volume":"242","author":"Shaoa","year":"2018","journal-title":"Food Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114525_bib41","doi-asserted-by":"crossref","first-page":"16340","DOI":"10.1074\/jbc.M200678200","article-title":"Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114525_bib42","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jid.2018.01.019","article-title":"Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase","volume":"138","author":"Mann","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114525_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-4632.2011.05305.x","article-title":"Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis","volume":"52","author":"Mishra","year":"2013","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1473-2165.2005.40202.x","article-title":"Hydroquinone and its analogues in dermatology -a potential health risk","volume":"4","author":"Westerhof","year":"2005","journal-title":"J. Cosmet. Dermatol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40257-015-0126-8","article-title":"Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments","volume":"16","author":"Simmons","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejmech.2022.114525_bib46","series-title":"Twentyfourth Directive 2000\/6\/EG Publication Nr L 056","year":"2000"},{"key":"10.1016\/j.ejmech.2022.114525_bib47","unstructured":"FDA. Department of Health and Human Services. Food and Drug Administration. Skin Bleaching Drug Products for Over-the-counter Human Use; Proposed Rule. 71 Federal Register 51146-5115521, 2006 (codified at 21 CFR Part 310)."},{"key":"10.1016\/j.ejmech.2022.114525_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113744","article-title":"Recent advances in the design and discovery of synthetic tyrosinase inhibitors","volume":"224","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","article-title":"A comprehensive review on tyrosinase inhibitors","volume":"34","author":"Zolghadri","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib50","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/ijms19030690","article-title":"Structure-activity relationships of thiazolyl resorcinols, potent and selective inhibitors of human tyrosinase","volume":"19","author":"Mann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib51","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ics.12694","article-title":"Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol)","volume":"43","author":"Roggenkamp","year":"2021","journal-title":"Int. J. Cosmet. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114525_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-017-1959-x","article-title":"Synthesis, characterization and evaluation of the anti-inflammatory activity of thiazolo[3,2-b][1,2,4]Triazole derivatives bearing pyridin-3\/4-yl moiety","volume":"26","author":"Toma","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114525_bib53","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bmc.2016.01.041","article-title":"Metal-based biologically active azoles and \u03b2-lactams derived from sulfa drugs","volume":"24","author":"Ebrahimi","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2015.08.005","article-title":"Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives","volume":"102","author":"Dawood","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114525_bib55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2022.114525_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114525_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1573406414666180524084023","article-title":"Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential antituberculosis agents","volume":"15","author":"Meta","year":"2019","journal-title":"Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4067\/s0716-10182020000300219","article-title":"Azoles de antes y ahora: una revisi\u00f3n [Azoles of then and now: a review]","volume":"37","author":"Nocua-B\u00e1ez","year":"2020","journal-title":"Rev Chilena Infectol"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114525_bib59","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/exd.12669","article-title":"The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-\/Akt-mediated tyrosinase degradation","volume":"24","author":"Chung","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114525_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7164\/antibiotics.49.513","article-title":"Melanoxazal, new melanin biosynthesis inhibitor discovered by using the larval haemolymph of the silkworm, Bombyx mori. Production, isolation, structural elucidation, and biological properties","volume":"49","author":"Takahashi","year":"1996","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2022.114525_bib62","first-page":"1","article-title":"A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship","volume":"18","author":"Peng","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"24","key":"10.1016\/j.ejmech.2022.114525_bib63","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1021\/bi200395t","article-title":"Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone","volume":"50","author":"Ismaya","year":"2011","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114525_bib64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/4193","article-title":"Crystal structure of a plant catechol oxidase containing a dicopper center","volume":"5","author":"Klabunde","year":"1998","journal-title":"Nat. Struct. Biol."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114525_bib65","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1074\/jbc.M509785200","article-title":"Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis","volume":"281","author":"Matoba","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib66","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ejmech.2014.11.033","article-title":"Recent advances in bioactive 1,2,4-triazole-3-thiones","volume":"97","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114525_bib67a","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s11030-020-10102-5","article-title":"Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: synthesis, kinetic mechanism, cytotoxicity and computational studies","volume":"25","author":"Vanjare","year":"2021","journal-title":"Mol. Divers."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2022.114525_bib67b","article-title":"Synthesis, antioxidant and anti-tyrosinase activity of 1,2,4-triazole hydrazones as antibrowning agents","volume":"341","author":"Peng","year":"2021","journal-title":"Food Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114525_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100058","article-title":"Synthesis of new 1,2,4-triazole-(thio)semicarbazide hybrid molecules: their tyrosinase inhibitor activities and molecular docking analysis","volume":"354","author":"Gultekin","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2022.114525_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104979","article-title":"Anti-melanogenesis and anti-tyrosinase properties of aryl-substituted acetamides of phenoxy methyl triazole conjugated with thiosemicarbazide: design, synthesis and biological evaluations","volume":"114","author":"Hosseinpoor","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bioorg.2019.01.036","article-title":"Synthesis and structure-activity relationship of tyrosinase inhibiting novel bi-heterocyclic acetamides: mechanistic insights through enzyme inhibition, kinetics and computational studies","volume":"86","author":"Butt","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114525_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/b001942i","article-title":"The synthesis of cyclic peptides","volume":"1","author":"Lambert","year":"2001","journal-title":"Journal of the Chemical Society, Perkin Transactions"},{"issue":"23","key":"10.1016\/j.ejmech.2022.114525_bib72","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1021\/ja00049a021","article-title":"Prediction of the best linear precursor in the synthesis of cyclotetrapeptides by molecular mechanic calculations","volume":"114","author":"Cavelier-Frontin","year":"1992","journal-title":"J. Am. Chem. Soc."},{"issue":"28","key":"10.1016\/j.ejmech.2022.114525_bib73","doi-asserted-by":"crossref","first-page":"10606","DOI":"10.1073\/pnas.0601490103","article-title":"Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis","volume":"103","author":"N\u00f6ren-M\u00fcller","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114525_bib74","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1021\/ol053095o","article-title":"Click chemistry as a route to cyclic tetrapeptide analogues: synthesis of cyclo-[Pro-Val-psi(triazole)-Pro-Tyr]","volume":"8","author":"Bock","year":"2006","journal-title":"Org. Lett."},{"issue":"21","key":"10.1016\/j.ejmech.2022.114525_bib75","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/S0040-4039(00)79177-5","article-title":"A novel cyclotetrapeptide produced by Lactobacillus helveticus as a tyrosinase inhibitor","volume":"34","author":"Kawagishi","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114525_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bioorg.2018.10.069","article-title":"1,2,3-Triazole-based kojic acid analogs as potent tyrosinase inhibitors: design, synthesis and biological evaluation","volume":"82","author":"Ashooriha","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112480","article-title":"Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors","volume":"201","author":"Ashooriha","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130241","article-title":"Design, synthesis, molecular modeling, and biological evaluation of novel kojic acid derivatives containing bioactive heterocycle moiety as inhibitors of tyrosinase and antibrowning agents","volume":"362","author":"He","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116222","article-title":"Novel 1,3,4-oxadiazole compounds inhibit the tyrosinase and melanin level: synthesis, in-vitro, and in-silico studies","volume":"41","author":"Vanjare","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114525_bib80","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/j.bmcl.2010.04.067","article-title":"Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors","volume":"20","author":"Lam","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib81","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/jf0521855","article-title":"Flavonoids as mushroom tyrosinase inhibitors: a fluorescence quenching study","volume":"54","author":"Kim","year":"2006","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114525_bib82","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1016\/j.bmc.2010.04.021","article-title":"New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site","volume":"18","author":"Ghani","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bioorg.2016.09.007","article-title":"Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors","volume":"69","author":"Tang","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114525_bib84","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.bmcl.2011.02.064","article-title":"Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells","volume":"21","author":"Ha","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114525_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bioorg.2017.08.002","article-title":"Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase","volume":"74","author":"Saeed","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2019.05.006","article-title":"Discovery of tropinone-thiazole derivatives as potent caspase 3\/7 activators, and noncompetitive tyrosinase inhibitors with high antiproliferative activity: rational design, one-pot tricomponent synthesis, and lipophilicity determination","volume":"175","author":"Piechowska","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2022.114525_bib87","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1016\/j.bmcl.2012.09.003","article-title":"Discovery of small molecules that inhibit melanogenesis via regulation of tyrosinase expression","volume":"22","author":"Song","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"7","key":"10.1016\/j.ejmech.2022.114525_bib88","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmc.2012.12.054","article-title":"Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors","volume":"21","author":"Zhou","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib89","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cbdd.13352","article-title":"Novel 1,3-oxazine-tetrazole hybrids as mushroom tyrosinase inhibitors and free radical scavengers: synthesis, kinetic mechanism, and molecular docking studies","volume":"93","author":"Qamar","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114525_bib90","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1096\/fj.06-6649rev","article-title":"Human skin pigmentation: melanocytes modulate skin color in response to stress","volume":"21","author":"Costin","year":"2007","journal-title":"Faseb. J."},{"issue":"27","key":"10.1016\/j.ejmech.2022.114525_bib91","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2174\/1568026616666160216160112","article-title":"Are human tyrosinase and related proteins suitable targets for melanoma therapy?","volume":"16","author":"Buitrago","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1600-0749.2000.130302.x","article-title":"Sorting and targeting of melanosomal membrane proteins: signals, pathways, and mechanisms","volume":"13","author":"Setaluri","year":"2000","journal-title":"Pigm. Cell Res."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114525_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161697","article-title":"Large-scale recombinant expression and purification of human tyrosinase suitable for structural studies","volume":"11","author":"Lai","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<171::AID-HUMU11>3.0.CO;2-X","article-title":"Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1)","volume":"10","author":"Spritz","year":"1997","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib95","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/1523-1747.ep12392743","article-title":"High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex","volume":"103","author":"Orlow","year":"1994","journal-title":"J. Invest. Dermatol."},{"issue":"Pt 24","key":"10.1016\/j.ejmech.2022.114525_bib96","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1242\/jcs.017913","article-title":"Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo","volume":"120","author":"Kobayashi","year":"2007","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114525_bib97","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1073\/pnas.97.11.5889","article-title":"Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism","volume":"97","author":"Halaban","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib98","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/bbrc.1997.8007","article-title":"Metal ligand-binding specificities of the tyrosinase-related proteins","volume":"242","author":"Furumura","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114525_bib99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/j.1460-2075.1992.tb05082.x","article-title":"A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase","volume":"11","author":"Tsukamoto","year":"1992","journal-title":"EMBO J."},{"issue":"46","key":"10.1016\/j.ejmech.2022.114525_bib100","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1002\/anie.201708214","article-title":"The recent crystal structure of human tyrosinase related protein 1 (HsTYRP1) solves an old problem and poses a new one","volume":"56","author":"Decker","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"49","key":"10.1016\/j.ejmech.2022.114525_bib101","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1002\/anie.201506994","article-title":"The structure of a plant tyrosinase from walnut leaves reveals the importance of \"Substrate-Guiding residues\" for enzymatic specificity","volume":"54","author":"Bijelic","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2022.114525_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/srep34993","article-title":"The unravelling of the complex pattern of tyrosinase inhibition","volume":"6","author":"Deri","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114525_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fgb.2012.10.004","article-title":"Melanin biosynthesis pathway in Agaricus bisporus mushrooms","volume":"55","author":"Weijn","year":"2013","journal-title":"Fungal Genet. Biol."},{"issue":"22","key":"10.1016\/j.ejmech.2022.114525_bib104","doi-asserted-by":"crossref","first-page":"13428","DOI":"10.1021\/acs.jmedchem.0c00994","article-title":"Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations","volume":"63","author":"Roulier","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib105","first-page":"6.15.1","article-title":"Purification of recombinant human tyrosinase from insect larvae infected with the baculovirus vector","volume":"89","author":"Dolinska","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114525_bib106","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/ijms21030895","article-title":"Human tyrosinase: temperature-dependent kinetics of oxidase activity","volume":"21","author":"Young","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib107","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/jdv.12051","article-title":"4-n-Butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation","volume":"27","author":"Kolbe","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2022.114525_bib108","first-page":"197","article-title":"4-(1-phenylethyl) 1,3-benzenediol: a new highly potent lightning agent","volume":"57","author":"Schmaus","year":"2006","journal-title":"J. Cosmet. Sci."},{"key":"10.1016\/j.ejmech.2022.114525_bib109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/B:JOPC.0000020080.21417.ff","article-title":"Inhibitory effects of hexylresorcinol and dodecylresorcinol on mushroom (Agaricus bisporus) tyrosinase","volume":"23","author":"Chen","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.ejmech.2022.114525_bib110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmb.2010.10.048","article-title":"First structures of an active bacterial tyrosinase reveal copper plasticity","volume":"405","author":"Sendovski","year":"2011","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114525_bib111","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jid.2019.02.013","article-title":"Effective tyrosinase inhibition by thiamidol results in significant improvement of mild to moderate melasma","volume":"139","author":"Arrowitz","year":"2019","journal-title":"J. Invest. Dermatol"},{"issue":"14","key":"10.1016\/j.ejmech.2022.114525_bib112","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.bmc.2018.05.047","article-title":"The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-\u03b2phenyl-\u03b1, \u03b2-unsaturated carbonyl scaffold","volume":"26","author":"Kim","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114525_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.csbj.2020.12.001","article-title":"In silico and in vitroinsights into tyrosinase inhibitors with a 2-thioxooxazoline-4-one template","volume":"19","author":"Choi","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422004275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:40:57Z","timestamp":1759329657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422004275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":112,"alternative-id":["S0223523422004275"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114525","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azole inhibitors of mushroom and human tyrosinases: Current advances and prospects of drug development for melanogenic dermatological disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114525"}}